Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review

Carolina Secreto, Filippo Fasano, Davide Stella, Mattia Novo, Barbara Botto, Marco Cerrano, Roberto Freilone, Alessandro Busca · 2026

Read Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review by Carolina Secreto, Filippo Fasano, Davide Stella, Mattia Novo, Barbara Botto, Marco Cerrano, Roberto Freilone, Alessandro Busca (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13314483.txt.

Description

Carolina Secreto and colleagues review infections after CAR-T cell therapy for lymphoid cancers in a 2026 paper. The therapy has reshaped care of these blood cancers, but infections are a frequent side effect and can derail a good result.

The review lays out a two-phase pattern. Early infections strike in the first 30 days after infusion and are mostly bacterial, while later ones lean viral or opportunistic, and deep fungal infections stay rare, as the authors report. Risk rests on both host traits, such as the disease and past treatments, and therapy traits, such as the cell product and storm-like side effects named CRS and ICANS in the report. Knowing the timetable helps teams time prevention drugs and watch the right threats at each stage.

Catalog record

CREATORCarolina Secreto, Filippo Fasano, Davide Stella, Mattia Novo, Barbara Botto, Marco Cerrano, Roberto Freilone, Alessandro Busca
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34607
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13314483

Browse the full library · About the Tower of Babel